A randomized, open-label study to determine the relative bioavailability of inhaled indacaterol maleate (with and without oral activated charcoal) delivered via the EPIC Test Fixture in healthy adult subjects
Latest Information Update: 12 Nov 2019
At a glance
- Drugs Indacaterol (Primary) ; Charcoal
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacogenomic; Pharmacokinetics
- Sponsors Novartis Healthcare
- 06 Aug 2013 New trial record